Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Cephalosporin + Penicillinase-Resistant Penicillin
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Mixed-flora skin and soft-tissue infections
- Diabetic foot infections
- Post-surgical wound infections
- Severe cellulitis with mixed flora suspected
- Bone and joint infections (adjunct)
Mechanism of Action
Cefixime binds penicillin-binding proteins (PBP-3) on gram-negative bacteria, inhibiting the final transpeptidation step of peptidoglycan synthesis. The result is bacterial cell wall destabilisation and osmotic lysis. Cefixime is resistant to many beta-lactamases produced by gram-negative organisms — distinguishing it from earlier cephalosporins. Dicloxacillin's bulky isoxazolyl side chain sterically prevents beta-lactamase hydrolysis, retaining activity against penicillinase-producing MSSA.
Dosage & Administration
- Adults: 1 tablet twice daily for 7–14 days depending on infection severity.
- SR matrix releases drug over 12 hours.
Side Effects
- GI upset, nausea, diarrhoea, mild rash.
- Rare: hypersensitivity, pseudomembranous colitis, hepatic enzyme elevation.
Contraindications
- Hypersensitivity to cephalosporins.
- Severe penicillin allergy (cross-reactivity ~10%).
- Renal impairment requires dose adjustment.
- History of GI disease (caution).
- Severe penicillin allergy.
- Infectious mononucleosis (Dicloxacillin rash risk).
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Alu Alu)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet?
Available pack sizes include: 10 x 10 (Alu Alu).
What is the MRP / trade price for Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet?
MRPs range from ₹3200 to ₹3200 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Cefixime 200 mg & Dicloxacilin 500 mg (Sustained release) Tablets Tablet?